In addition, the peritoneal injection of melatonin to the DNFB-treated AD mouse model inhibits serum IgE levels and cytokine secretion of IL-4 and IFN-γ from activated CD4+ T cells [18]. This evidence concerns the gene IFNG and Alzheimer disease.